Van Brakel W H
TLM India, New Delhi, India.
Lepr Rev. 2000 Dec;71 Suppl:S146-53. doi: 10.5935/0305-7518.20000086.
Leprosy causes a 'mononeuritis multiplex' of immunological origin that results in autonomic, sensory and motor neuropathy. When detected and treated early, primary impairments may be reversible. However, 11-51% of patients do not recover. In addition, 33-56% of newly registered patients already have clinically detectable impairments, often no longer amenable to drug treatment. Among new patients, 6-27% present with secondary impairments, such as wounds, contractures and shortening of digits. All patients with impairments should be taught methods to prevent further impairment and subsequent disability (POID). As the result of impairments, many people experience limitation of activities of daily living, which can be partially overcome with the help of assistive devices, training, and surgery. As a result of these limitations, because of visible impairments, or simply because of the diagnosis 'leprosy', many people are restricted in their participation in society. Many overcome activity limitations and participation restrictions without assistance, despite residual impairments. However, some require intervention, such as physical or occupational therapy, reconstructive surgery or temporary socioeconomic assistance. Information on these issues is not collected routinely, and the few tools that exist to measure the severity or extent of impairment have not been widely used, nor have they been used to generate cohort-based statistics. There are no agreed indicators for monitoring POID activities or rehabilitation interventions. Work in the general field of rehabilitation has resulted in the ICIDH-2, which provides a conceptual framework for rehabilitation and the entire area of 'consequences of health conditions'. Although experience to date is very limited, the conceptual framework appears appropriate to leprosy. Data on the prevalence and incidence of primary and secondary impairments have been reported from several countries, the link between impairments and activity limitations has been investigated, and a few studies of the magnitude of the need for rehabilitation have been reported. Research priorities include studies of methods to improve detection of autonomic, sensory and motor neuropathy; trials of alternative drugs or regimens for treating neuropathy; studies of the use of various POID-monitoring systems that may be derived from these; studies of the design and use of instruments to assess limitations of activities and restrictions on participation; assessments of needs for rehabilitation and the development of methods to do these; studies of the efficacy of various types of rehabilitation interventions for particular conditions; and studies of the cost-effectiveness of such interventions.
麻风病会引发一种免疫源性的“多发性单神经炎”,导致自主神经、感觉和运动神经病变。若能早期发现并治疗,原发性损伤可能可逆。然而,11%至51%的患者无法康复。此外,33%至56%的新登记患者已有临床可检测到的损伤,通常不再适合药物治疗。在新患者中,6%至27%存在继发性损伤,如伤口、挛缩和手指缩短。所有有损伤的患者都应学习预防进一步损伤和后续残疾(预防损伤和残疾,POID)的方法。由于损伤,许多人日常生活活动受限,借助辅助器具、训练和手术可部分克服这些限制。由于这些限制,或因明显的损伤,或仅仅因为“麻风病”的诊断,许多人参与社会受到限制。尽管有残留损伤,许多人无需帮助就能克服活动限制和参与限制。然而,有些人需要干预,如物理治疗或职业治疗、重建手术或临时社会经济援助。关于这些问题的信息并非常规收集,现有的少数用于衡量损伤严重程度或范围的工具未得到广泛使用,也未用于生成基于队列的统计数据。目前尚无用于监测预防损伤和残疾活动或康复干预的商定指标。康复领域的工作产生了《国际功能、残疾和健康分类》第二版(ICIDH - 2),它为康复以及“健康状况后果”的整个领域提供了概念框架。尽管目前的经验非常有限,但该概念框架似乎适用于麻风病。几个国家已报告了原发性和继发性损伤的患病率和发病率,对损伤与活动限制之间的联系进行了调查,并且有一些关于康复需求规模的研究报告。研究重点包括改善自主神经、感觉和运动神经病变检测方法的研究;治疗神经病变的替代药物或方案的试验;可能由此衍生的各种预防损伤和残疾监测系统使用情况的研究;评估活动限制和参与限制的仪器设计和使用的研究;康复需求评估以及开展此类评估方法的研究;针对特定情况的各种康复干预效果的研究;以及此类干预成本效益的研究。